| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. | J Natl Cancer Inst | 2003 | 3.77 |
| 2 | The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Transfusion | 2008 | 1.08 |